BiotechTube

Combogesic® tablets + Acetaminophen 500mg + Placebo

Phase 3Recruiting
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Post Operative Pain, Acute

Conditions

Post Operative Pain, Acute

Trial Timeline

Feb 1, 2026 → Oct 1, 2026

NCT ID
NCT07225140

About Combogesic® tablets + Acetaminophen 500mg + Placebo

Combogesic® tablets + Acetaminophen 500mg + Placebo is a phase 3 stage product being developed by AFT Pharmaceuticals for Post Operative Pain, Acute. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07225140. Target conditions include Post Operative Pain, Acute.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT07225140Phase 3Recruiting

Competing Products

20 competing products in Post Operative Pain, Acute

See all competitors
ProductCompanyStageHype Score
PRF110- oily solution (Ropivacaine)PainReformPhase 2
44
PRF110PainReformPhase 2
44
ENZ215 + ProliaAlkem LaboratoriesPhase 3
77
teriparatide + teriparatide + Placebo + Calcium Supplement + Vitamin D SupplementEli LillyPhase 3
77
raloxifene + PlaceboEli LillyApproved
85
MBX 1416 (INN imapextide)MBX BiosciencesPhase 2
47
MBX 1416 (Part A) + MBX 1416 (Part B) + Placebo + MBX 1416 (Part C)MBX BiosciencesPhase 1
28
teriparatide 20 micrograms/day subcutaneous + calcitonin 100 IU/day subcutaneousEli LillyPhase 3
77
teriparatide 20 micrograms/day subcutaneous + salmon calcitonin 100 IU/day subcutaneousEli LillyPhase 3
77
CT-P41 + US-licensed ProliaCelltrionPhase 3
77
LetrozoleChugai PharmaceuticalPhase 2
52
Eldecalcitol soft capsulesChugai PharmaceuticalPre-clinical
23
LetrozoleChugai PharmaceuticalPhase 2
52
LetrozoleChugai PharmaceuticalPhase 2
52
Placebo + DS-5565Daiichi SankyoPre-clinical
23
YM177 + etodolac + PlaceboAstellas PharmaPhase 3
77
QUTENZAAstellas PharmaApproved
85
QutenzaAstellas PharmaPre-clinical
23
CelecoxibAstellas PharmaPre-clinical
23
ASP8477 + PlaceboAstellas PharmaPhase 2
52

Other Products from AFT Pharmaceuticals

Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion)Phase 3
69
Maxigesic IV + IV Acetaminophen + IV Ibuprofen + Placebo IVPhase 3
69
Maxigesic 325 + Acetaminophen + Ibuprofen + PlaceboPhase 3
69
Maxigesic® IVPhase 3
69
Acetaminophen + Maxigesic 325 + Ibuprofen + PlaceboPhase 3
69